| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $57.4B | $53.0B | $50.0B | $42.4B | $40.5B | $39.1B | $39.5B | $39.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | $24.3B |
| R&D Expense | $9.9B | $8.9B | $8.6B | $7.2B | $6.5B | $6.1B | $6.0B | $6.1B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $17.7B | $15.4B | $13.1B | $10.9B | $15.2B | $13.9B | $13.5B | $13.7B |
| Net Income | $12.4B | $10.5B | $8.5B | $6.7B | $13.7B | $10.1B | $11.1B | $3.8B |
| EPS (Basic) | $4.46 | $3.82 | $3.15 | $2.49 | $4.67 | $3.16 | $3.05 | $0.93 |
| EPS (Diluted) | $4.34 | $3.71 | $3.07 | $2.41 | $4.55 | $3.08 | $2.97 | $0.90 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $168.4B | $141.0B | $134.4B | $109.3B | $131.1B | $115.4B | $108.7B | $137.3B |
| Current Assets | $24.6B | $22.6B | $21.0B | $31.6B | $55.6B | $52.1B | $46.4B | $76.0B |
| Cash & Equivalents | $10.8B | $10.5B | $9.8B | $21.4B | $30.1B | $37.2B | $20.5B | $21.6B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $32.6B | $31.5B | $23.1B | $19.5B | $24.2B | $17.2B | $18.6B | $19.2B |
| Stockholders' Equity | $20.5B | $8.7B | $1.1B | $-6.2B | $5.2B | $12.1B | $21.8B | $45.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $20.8B | $18.7B | $17.2B | $9.5B | $15.9B | $13.1B | $14.6B | $15.4B |
| Investing Cash Flow | $-21.7B | $-7.4B | $-36.5B | $11.2B | $-13.1B | $9.8B | $26.6B | $-5.6B |
| Capital Expenditures | $21.2B | $6.9B | $8.7B | $4.5B | $2.1B | $1.6B | $1.7B | $1.7B |
| Financing Cash Flow | $1.1B | $-10.6B | $7.9B | $-29.1B | $-10.4B | $-6.1B | $-42.1B | $-10.0B |